Gilead Sciences Inc Stock
Price
Target price
€102.58
€102.58
-2.920%
-3.06
-2.920%
€118.99
12.12.25 / Tradegate
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Gilead Sciences Inc Stock
A loss of -2.920% shows a downward development for Gilead Sciences Inc.
The stock is an absolute favorite of our community with 37 Buy predictions and no Sell predictions.
With a target price of 118 € there is a slightly positive potential of 15.03% for Gilead Sciences Inc compared to the current price of 102.58 €.
So far the community has only identified positive things for Gilead Sciences Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | -2.920% | -1.479% | -3.699% | 16.212% | 14.206% | 22.046% | 104.546% |
| Regeneron Pharmaceuticals Inc. | -1.700% | 2.399% | 7.342% | -10.766% | -6.623% | -10.399% | 59.535% |
| Exact Sciences | 0.300% | -0.369% | 46.584% | 44.720% | 59.011% | 100.533% | -19.111% |
| Incyte Corp. | -1.780% | -7.654% | -12.952% | 20.154% | 23.737% | 4.030% | 21.265% |
Comments
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Morgan Stanley from $147.00 to $151.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Wells Fargo & Company from $145.00 to $150.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $140.00 price target on the stock.
Show more
Ratings data for GILD provided by MarketBeat
